GlassScriptPhysician profile
Sumra Rathore
NPI 1760440481
$632.45
in general payments reported to CMS, 2019-2025
8 companies · $23.57 in 2025
The $23.57 reported for 2025 was less than what a typical Anatomic Pathology & Clinical Pathology provider received nationally (typical 2025 total: $50.59).
See the full distribution for Anatomic Pathology & Clinical Pathology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2021: $113 · 2022: $75.73 · 2024: $295 · 2025: $23.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $318.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $143.41 | 2024-2025 | Panther Fusion, Thinprep 2000 Processor, Aptima |
| Pacira Pharmaceuticals Incorporated | $124.99 | 2019 | |
| Daiichi Sankyo INC. | $113.42 | 2021 | |
| Becton, Dickinson and Company | $111.40 | 2024 | Bd Max System, Bd Max Instrument |
| E.R. Squibb & Sons, L.L.C. | $60.00 | 2022 | |
| Celgene Corporation | $47.35 | 2024 | |
| Promega Corporation | $16.15 | 2024 | Oncomate Msi Dx Analysis System |
| Biocartis US, INC | $15.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sumra Rathore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.